肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

长春碱类药物治疗恶性淋巴瘤中国专家共识（2017）

2017-04-05 MedSci MedSci原创

长春碱类药物恶性淋巴瘤
关注

近十几年来，恶性淋巴瘤发病率呈上升趋势，已跻身我国十大恶性肿瘤之一。长春碱类药物在各类恶性淋巴瘤的治疗中应用广泛，在临床中应注意不同长春碱类药物药理毒理的相似性和差异性，以便针对不同患者进行合理的药物选择。 神经损伤是长春碱类药物的主要毒性之一，涉及周围神经损伤和自主神经损伤，毒性表现多样且广泛，在长春碱类药物的使用过程中应引起注意，一旦出现需及时应对，给予神经保护、药物替代等措施。

近十几年来，恶性淋巴瘤发病率呈上升趋势，已跻身我国十大恶性肿瘤之一。长春碱类药物在各类恶性淋巴瘤的治疗中应用广泛，在临床中应注意不同长春碱类药物药理毒理的相似性和差异性，以便针对不同患者进行合理的药物选择。

神经损伤是长春碱类药物的主要毒性之一，涉及周围神经损伤和自主神经损伤，毒性表现多样且广泛，在长春碱类药物的使用过程中应引起注意，一旦出现需及时应对，给予神经保护、药物替代等措施。

【指南全文】

拓展指南：与恶性淋巴瘤相关指南：

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1844715, encodeId=899e1844e1533, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu May 11 10:35:00 CST 2017, time=2017-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741419, encodeId=a4071e41419e1, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sun Nov 05 07:35:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954985, encodeId=587a1954985a2, content=<a href='/topic/show?id=fa59969e06c' target=_blank style='color:#2F92EE;'>#长春碱类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96970, encryptionId=fa59969e06c, topicName=长春碱类药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Thu Nov 09 08:35:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441593, encodeId=2953144159338, content=<a href='/topic/show?id=91885291e03' target=_blank style='color:#2F92EE;'>#恶性淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52917, encryptionId=91885291e03, topicName=恶性淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72614872530, createdName=HinsMax, createdTime=Fri Apr 07 06:35:00 CST 2017, time=2017-04-07, status=1, ipAttribution=)]
    2017-05-11 snowpeakxu

    #专家共识#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1844715, encodeId=899e1844e1533, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu May 11 10:35:00 CST 2017, time=2017-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741419, encodeId=a4071e41419e1, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sun Nov 05 07:35:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954985, encodeId=587a1954985a2, content=<a href='/topic/show?id=fa59969e06c' target=_blank style='color:#2F92EE;'>#长春碱类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96970, encryptionId=fa59969e06c, topicName=长春碱类药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Thu Nov 09 08:35:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441593, encodeId=2953144159338, content=<a href='/topic/show?id=91885291e03' target=_blank style='color:#2F92EE;'>#恶性淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52917, encryptionId=91885291e03, topicName=恶性淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72614872530, createdName=HinsMax, createdTime=Fri Apr 07 06:35:00 CST 2017, time=2017-04-07, status=1, ipAttribution=)]
    2017-11-05 12498f1em19(暂无昵称)

    #中国专家共识#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1844715, encodeId=899e1844e1533, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu May 11 10:35:00 CST 2017, time=2017-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741419, encodeId=a4071e41419e1, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sun Nov 05 07:35:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954985, encodeId=587a1954985a2, content=<a href='/topic/show?id=fa59969e06c' target=_blank style='color:#2F92EE;'>#长春碱类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96970, encryptionId=fa59969e06c, topicName=长春碱类药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Thu Nov 09 08:35:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441593, encodeId=2953144159338, content=<a href='/topic/show?id=91885291e03' target=_blank style='color:#2F92EE;'>#恶性淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52917, encryptionId=91885291e03, topicName=恶性淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72614872530, createdName=HinsMax, createdTime=Fri Apr 07 06:35:00 CST 2017, time=2017-04-07, status=1, ipAttribution=)]
    2017-11-09 仁医06

    #长春碱类药物#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1844715, encodeId=899e1844e1533, content=<a href='/topic/show?id=5d2f206482e' target=_blank style='color:#2F92EE;'>#专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20648, encryptionId=5d2f206482e, topicName=专家共识)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=568152, createdName=snowpeakxu, createdTime=Thu May 11 10:35:00 CST 2017, time=2017-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741419, encodeId=a4071e41419e1, content=<a href='/topic/show?id=c2c621665c4' target=_blank style='color:#2F92EE;'>#中国专家共识#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21665, encryptionId=c2c621665c4, topicName=中国专家共识)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=218a34934063, createdName=12498f1em19(暂无昵称), createdTime=Sun Nov 05 07:35:00 CST 2017, time=2017-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1954985, encodeId=587a1954985a2, content=<a href='/topic/show?id=fa59969e06c' target=_blank style='color:#2F92EE;'>#长春碱类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96970, encryptionId=fa59969e06c, topicName=长春碱类药物)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55683, createdName=仁医06, createdTime=Thu Nov 09 08:35:00 CST 2017, time=2017-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1441593, encodeId=2953144159338, content=<a href='/topic/show?id=91885291e03' target=_blank style='color:#2F92EE;'>#恶性淋巴瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52917, encryptionId=91885291e03, topicName=恶性淋巴瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72614872530, createdName=HinsMax, createdTime=Fri Apr 07 06:35:00 CST 2017, time=2017-04-07, status=1, ipAttribution=)]
    2017-04-07 HinsMax

    #恶性淋巴瘤#

    0